Quantcast
  Sunday - January 11th, 2026
×

What can we help you find?

Open Menu

Health & Wellbeing

iGen More Likely Than Other Generations To Be Depressed

A 2015 survey found that two out of three U.S. teens owned an iPhone. For this reason, the generation of kids born after 1995 is called iGen, coined by author Jean Twenge, author of a book on the subject. According to the Pew Research Center, smart phone ownership crossed the 50 percent threshold in late […]

Read More

A New Vaccine for Cancer Is On The Horizon

In 2018, an estimated 1.7 million new cases of cancer will be diagnosed in the United States and over 600 thousand people will die from the disease. Recently, a phase I trial was conducted testing a personalized vaccine’s ability to hold an aggressive group of cancers in check. The trial is the first step to […]

Read More

Living Diagnosis for Brain Injury on the Horizon

Brain injury has been a hot topic of conversation since Dr. Bennet Omalu, a forensic pathologist, conducted the autopsy of Pittsburgh Steelers center Mike Webster in 2002. The autopsy led to his discovery of a new disease that he named chronic traumatic encephalopathy, or CTE. CTE is the term used to describe brain degeneration likely […]

Read More

Enjoy Spring Cycling Safely!

May is National Bike Month and Bike to Work Day isn’t far behind, so now is the perfect time to dust off the bike, lube the chain, pump up the tires and take a ride. Don’t have a bike? B-cycle is a public bicycle sharing company based in Waterloo, Wisconsin. It has 47 local systems […]

Read More

There’s A Pill to Reduce The Risk of Contracting HIV

Did you know there is a drug available in the U.S. designed to prevent HIV infection? PrEP, or Pre-Exposure Prophylaxis, is anti-HIV medication to keep HIV negative people from becoming infected. PrEP is approved by the FDA and studies have shown that PrEP reduces the risk of getting HIV by more than 90% when used […]

Read More

Japan Will Soon Have A Drug To Combat The Flu

Last week, the Wall Street Journal reported that Japanese officials approved the single-dose drug, known as Xofluza, for use in that country. In a clinical trial, Japanese and American patients who took the drug when they had the flu saw the virus wiped out, on average, in 24 hours.  The drug will be available in […]

Read More
Load More
Boulder Colorado Air Quality

A Day on Boulder Creek

Community Partners